CA
NZ
UK
AU
IND
US
● Anbio Biotechnology shares have added to recent gains, closing near $7.90, up 16.01%, with relativeVolumeonly modestly elevated at around 1.48.
● Nutriband shares have surged to $5.11, up 9.51%, with relative turnover hitting 20.2 times normal on roughly 257,000 shares, an extraordinary spike for a company whose daily trading is usually sleepy.
● OmniAb shares have risen to $4.71, up 8.78%, on relativeVolumeof just 0.57, below the stock's average.
● Generate Biomedicines shares have extended a strong late-summer run, climbing to $17.72, up 9.93%, onVolumeof roughly 2.5 million shares running about 3.5 times its recent norm.
● Faeth Therapeutics shares have climbed to $34.71, up 8.47%, without a discrete, company-issued announcement identified to explain the single-day gain.
● EUDA Health Holdings shares have risen to about $15.40, up 16.58%, on fewer than 10,000 shares traded, aVolumelevel at which a handful of orders can produce a large percentage move.
● Devoted Health issued aMedicareAdvantage coverage policy for Barostim, covering patients who meet FDA-approved indications as well as those enrolled in a related clinical trial, the second major insurer to adopt such a policy.
● BioVie shares have added another leg to a volatile August, rising to $2.14, up 9.74%, on relativeVolumeof just 0.08, a small fraction of the frenzied turnover the stock saw earlier in the month.
● BioStem Technologies shares have pushed higher, closing up 10.73% at $3.92, on relativeVolumeof roughly 0.76 times the stock's norm, meaning fewer shares changed hands than on an average session.
● Alvotech shares have climbed to close near $5.25, up 18.51%, lifting the IcelandicBiosimilarsdeveloper'sMarket Valueback toward $2.05 billion, by far the largest company among recent speculative movers.
Please wait processing your request...